Skip to content

APOTHEEK DE WINTER - DEVOS

Active
Private limited companyfounded 1990active for 36 yearsBaronstraat 62, 8870 Izegem, BelgiumKBO/BCE: BE 0440.567.961
Summary

APOTHEEK DE WINTER - DEVOS has been active since 1990 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €295,364 and a net result of €132,266. Equity is shrinking by about 9.2% per year across the filed financial years. Its solvency ranks better than 65% of 12,397 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€570,552total assets 2025
Staff
2.1 FTE
Equity
€295,364
Profit
€132,266
Turnover not published (abbreviated format)
Financial health
91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
  • OllinvestDirector · permanent representative Oliver Van der Maat
  • PharkomDirector · permanent representative Matthias Delbeke
  • STOFIMMODirector · permanent representative Kristof Beheyt
Accounts 57 days early1 of 9 deeds read
Why 91raises risk1 change of registered office in 24 monthslowers riskLiquidity: current ratio 1.94, cash €201,076Founded in 1990Equity €295,364 (51.8% of total assets)Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 77% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 77+8
equity 51.8% of total assets
Liquidity 70+7
short-term debt 48.2% · cash 35.2%
Profitability 98+10
return on assets 23.2%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,192 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026lowest value 03-2026: 0.1%● unchanged vs 02-2026lowest value 04-2026: 0.1%● unchanged vs 03-2026lowest value 05-2026: 0.1%● unchanged vs 04-2026lowest value 06-2026: 0.1%● unchanged vs 05-2026lowest value 07-2026: 0.1%● unchanged vs 06-2026lowest value 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026highest value
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.94, compared with 1.8 in 2024; short-term debt: 48.2% and cash: 35.2% of total assets), and 48.2% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 66% on solvency, 76% on liquidity, 90% on profitability and 77% on growth.

The bankruptcy probability was computed on 12-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Liquidity: current ratio 1.94, cash €201,076
NBB · annual accounts
lowers risk · Founded in 1990
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Equity €295,364 (51.8% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 05-12-2025, 57 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
57 days early
2024
46 days early
2023
50 days early
2022
42 days early
2021
40 days early
2020
6 days early
2019
43 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 41 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 16 December (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end12-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Appointments: BV PHARKOM, BV STOFIMMO and…Permanent representatives: Matthias Delbeke, Kristof…
  2. Annual accounts filedfinancial year 2025 · abbreviated…
  3. Highest result from 2019 to 2025net €132,266 ▲56.2%

Key points

  • Board changedlatest change 29-07-2026 · 3 in office 3 joined · 1 left View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: Among the best 20% on net resultsector median €28,327 · 12,385 companies €132,266 View
  • Positive: 7 profitable years in a rowprofit 2025: €132,266 7 years View
  • Positive: Equity rose in 2025from €235,597 to €295,364 ▲ 25.4% View

By topic

Financials

Financial year
2025
Total assets
€570,552
Profit
€132,266
Solvency
51.8%
Total assets▲ 5.7%
Net result
20192025
Go to Financials

Timeline

Events
37
Since
1992
Next accounts
by 31-01-2027
  1. 16-12-2024Annual accounts filed
  2. 12-12-2023Annual accounts filed
  3. 20-12-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
20-05-1990
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.